Literature DB >> 9115960

Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.

K C O'Briant1, G Bepler.   

Abstract

We have reported frequent allele loss for two separate regions identified by the markers D11S12 and HRAS on chromosome 11p15.5. D11S12 allele loss was associated with tumor stage and type and HRAS allele loss with cigarette consumption, sex, and survival. To positionally clone the putative tumor suppressor genes located in these regions, we here report a reduction in the size of these intervals to approximately 250 kb. The markers used, ordered from centromere to telomere, were D11S932 -D11S1331-D11S1760-D11S1323-D11S4891 (HBB)-D11S1758-D11S12-D11S988-D11S860-D11S131 8-TH-HRAS-D11S1363-D11S2071. We analyzed 44 tissue pairs from patients with primary lung cancer. The smallest common regions of allele loss were located between D11S1758 and D11S12 in the centromeric region of chromosome segment 11p15.5 (region of LOH on chromosome 11 in lung cancer, LOH11A) and between HRAS and D11S1363 in the telomeric region (region of LOH on chromosome 11 in lung cancer, LOH11B). Loss of heterozygosity was observed in 24/39 (62%) primary lung cancers informative for LOH11A and in 17/34 (50%) informative for LOH11B. The pattern of allele loss strongly suggests that two lung cancer suppressor genes are located on chromosome segment 11p15.5, one between D11S1758 and D11S12 and the other between HRAS and D11S1363. The estimated physical size of each of these regions is 250 kb.

Entities:  

Mesh:

Year:  1997        PMID: 9115960     DOI: 10.1002/(sici)1098-2264(199702)18:2<111::aid-gcc5>3.0.co;2-5

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  An 84-kilobase physical map and repeat polymorphisms of the gastrin/cholecystokinin brain receptor region at the junction of chromosome segments 11p15.4 and 15.5.

Authors:  K C O'Briant; S Y Ali; H U Weier; G Bepler
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

Review 2.  Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Authors:  Christopher R Bohl; Sitaram Harihar; Warren L Denning; Rahul Sharma; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2013-12-06       Impact factor: 4.599

3.  Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

Authors:  I I Wistuba; J Berry; C Behrens; A Maitra; N Shivapurkar; S Milchgrub; B Mackay; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

4.  Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.

Authors:  Susanna Petzmann; Reinhard Ullmann; Iris Halbwedl; Helmut H Popper
Journal:  Virchows Arch       Date:  2004-07-03       Impact factor: 4.064

5.  Loss of the eukaryotic initiation factor 3f in pancreatic cancer.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; John T Cunningham; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

6.  miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.

Authors:  Antonis Giannakakis; Raphael Sandaltzopoulos; Joel Greshock; Shun Liang; Jia Huang; Kosei Hasegawa; Chunsheng Li; Ann O'Brien-Jenkins; Dionyssios Katsaros; Barbara L Weber; Celeste Simon; George Coukos; Lin Zhang
Journal:  Cancer Biol Ther       Date:  2007-11-14       Impact factor: 4.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.